Gravitas Institute conducts in-depth research on the impact chronic or life threatening disease has on the brain in order to advance the interdisciplinary capability and reimbursement support that doctors need to comprehensively care for their patients. Gravitas works collaboratively with scientific, medical, physician, healthcare, patient advocacy, academic, and Health IT experts and organizations that need the research we oversee in order to advance innovative solutions, but is too expensive to do on their own. This collaborative approach also insures that the medical specialists that treat the primary disease work alongside Neurologists, Psychiatrists, and neuroscience experts to develop evidence based diagnostic and treatment models that reduce the severity of two co-occurring conditions.
Managing multiple conditions successfully will dramatically reduce the burden of physical decline and its cost. It will require advanced interdisciplinary knowledge by doctors, Health IT systems that can expand the capability and capacity of an outpatient clinical staff, as well as better guidelines for treatment planning and reimbursement. The cost and time to provide the clinical study evidence, measure outcomes of the resulting care models, demonstrate the health and fiscal value, and show measureable patient adoption is cost prohibitive for any single organization. Gravitas is bringing the experts, stakeholders, and Health IT innovators to the same table in order to share in the cost, the peer-review, and the benefits of the research. This will affordably hasten both clinical advancement and adoption of evidence based metrics used for the development or purchase of technology.
The Gravitas approach is to study each chronic or life threatening disease and its specific brain impact using systematic study of clinical research, patient health record data analysis to determine the disease pathway of both conditions, the transactional data to uncover the true cost of treating or not treating the brain causes or results of disease, and health consumer research to better match illness with what people will follow-through on. This detailed approach not only provides all of the evidence based support needed to improve treatment guidelines and reimbursement policy, but to accurately provide high quality care across providers, teams, and payers.
Gravitas Research Partners funding and prioritization input supports the work of hand-picked, multi-disciplined expert teams of doctors, scientists, biostatisticians, and informaticists to develop and oversee medical research studies. They, along with other donations or grants, also support a data commons that aggregates, harmonizes, and analyzes vast repositories that are developed into chronic or life threatening disease profiles. We share these profiles and the ability to study them with our Research Partners in order to quickly and cost effectively develop high quality products and services.
Interestingly, patients are now being asked, through new policy, to engage in the decisions and personal choices that effect their wellness. Today, almost 80% of the entire US population has depression, anxiety, bipolar, schizophrenia, addiction, dementia, Alzheimer's, stroke, Traumatic Brain Injury(TBI), Autism, or is getting treatment for cancer that is known to cause cognitive impairment, making few able to make clear, intellectual decisions. To borrow from today's stigma induced nomenclature, is this crazy or stupid? Gravitas research is inclusive of a national health consumer research study to find out how people make decisions, what kind of support they need from their doctors' offices, and what types of technology they will use to support self-management.